← Eichor
Study identifier: NCT04451278 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy

Condition: Epilepsy  ·  Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

PhaseN/A
Planned participants200
Who can joinAll sexes, 6 Years to 18 Years
Healthy volunteersNo

About this study

Resting-state functional MRI (r-fMRI) has emerged in recent years to analyze resting networks. It allows, without active participation of the patients, to identify and analyze the different functional brain networks. The analysis of r-fMRI can be done thanks to the graph theory, which is based on the based on the calculation of quantifiable parameters applied to the functional network studied, making it possible to assess its effectiveness. To the knowledge of the investigators, no study has used graph theory applied to r-fMRI data in order to obtain parameters useful for the useful parameters for the individual prognosis of children who have to be operation for drug-resistant lesional epilepsy.

This description comes directly from the study's public registry record.

Talk to the study team

Sidney KRYSTAL  ·  01 48 03 65 65  ·  skrystal@for.paris

Amelie YAVCHITZ  ·  01 48 03 65 65  ·  ayavchitz@for.paris

Always discuss trial participation with your own doctor first.

Locations (1)

Fondation A De RothschildParis, PARIS, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04451278